PET/CT better than standard tests for advanced breast cancer

01/3/2013 | (free registration)

FDG-PET/CT performed better than standard imaging, including bone scans, chest radiography and CT scans, in accurately detecting lesions in the chest, abdomen and bones in patients with locally advanced breast cancer, according to a study published in the Journal of Nuclear Medicine. FDG-PET/CT also modified disease staging in 52% of patients, allowing for an improvement in treatment. FDG-PET/CT identified distant metastases in 37% of patients, compared with 24% for conventional imaging, the study said.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR